6C4C.3

ICD-11 MMS 2026-01

MDMA or related drug intoxication, including MDA

Description

MDMA or related drug intoxication, including MDA is a clinically significant transient condition that develops during or shortly after the consumption of MDMA or related drugs that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of MDMA or related drugs and their intensity is closely related to the amount of MDMA or a related drug consumed. They are time-limited and abate as MDMA or a related drug is cleared from the body. Presenting features may include increased or inappropriate sexual interest and activity, anxiety, restlessness, agitation, and sweating. In rare instances, usually in severe intoxication, use of MDMA or related drugs, including MDA can result in dystonia and seizures. Sudden death is a rare but recognised complication.

Index terms

  • MDMA or related drug intoxication, including MDA
  • Ecstasy or related drug intoxication

Exclusions from above levels

  • QE11.6 – Hazardous use of MDMA or related drugs
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C4C.0 – Episode of harmful use of MDMA or related drugs, including MDA
  • 6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA
  • 6C4C.2 – MDMA or related drug dependence, including MDA
  • 6C4C.4 – MDMA or related drug withdrawal, including MDA
  • 6C4C.5 – MDMA or related drug-induced delirium, including MDA
  • 6C4C.6 – MDMA or related drug-induced psychotic disorder, including MDA
  • 6C4C.7 – Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
  • 6C4C.Y – Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
  • 6C4C.Z – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified

Foundation entity

MDMA or related drug intoxication, including MDA – http://id.who.int/icd/entity/1574982062

Allowed postcoordination axes

Part of: 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders